Mesa Laboratories (NASDAQ:MLAB) Receives Media Impact Rating of 0.12

Media headlines about Mesa Laboratories (NASDAQ:MLAB) have been trending somewhat positive on Thursday, according to Accern Sentiment. Accern rates the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Mesa Laboratories earned a coverage optimism score of 0.12 on Accern’s scale. Accern also assigned media coverage about the medical instruments supplier an impact score of 46.1256677447706 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Here are some of the news headlines that may have impacted Accern Sentiment Analysis’s analysis:

• Signal Bay Inc : Signal Bay Expands and Expands Right Into World’s Biggest Cannabis Market (4-traders.com)
• No fax required: Pay day loans costa mesa, california: $1000 approved in 5 mins (channelbuzz.ca)
• Signal Bay, Inc. Parent Company of EVIO Labs provides Corporate Update (globenewswire.com)
• Mesa Laboratories, Inc. (NASDAQ:MLAB) Given Consensus Rating of “Strong Buy” by Brokerages (americanbankingnews.com)

Mesa Laboratories (NASDAQ MLAB) traded down 0.94% during mid-day trading on Thursday, reaching $143.70. The company had a trading volume of 8,509 shares. The stock has a 50 day moving average price of $144.93 and a 200-day moving average price of $134.47. Mesa Laboratories has a 12-month low of $102.14 and a 12-month high of $169.80. The stock has a market capitalization of $537.01 million, a P/E ratio of 49.38 and a beta of 0.46.

Mesa Laboratories (NASDAQ:MLAB) last announced its earnings results on Wednesday, June 7th. The medical instruments supplier reported $1.24 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.24. The business had revenue of $24.30 million for the quarter, compared to analyst estimates of $27.10 million. Mesa Laboratories had a return on equity of 17.67% and a net margin of 11.94%. Equities analysts anticipate that Mesa Laboratories will post $3.06 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 15th. Shareholders of record on Thursday, August 31st will be paid a $0.16 dividend. The ex-dividend date is Tuesday, August 29th. This represents a $0.64 dividend on an annualized basis and a yield of 0.44%. Mesa Laboratories’s dividend payout ratio is currently 21.99%.

Separately, Zacks Investment Research lowered Mesa Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, June 10th.

COPYRIGHT VIOLATION NOTICE: “[[title]]” was reported by [[site]] and is owned by of [[site]]. If you are reading this news story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this news story can be read at [[permalink]].

In other Mesa Laboratories news, Director Robert V. Dwyer sold 11,150 shares of the company’s stock in a transaction dated Friday, June 16th. The stock was sold at an average price of $139.46, for a total value of $1,554,979.00. Following the transaction, the director now directly owns 80,671 shares in the company, valued at approximately $11,250,377.66. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Glenn E. Adriance sold 4,000 shares of the company’s stock in a transaction dated Friday, June 9th. The stock was sold at an average price of $148.98, for a total value of $595,920.00. Following the completion of the transaction, the insider now owns 10,000 shares in the company, valued at $1,489,800. The disclosure for this sale can be found here. Insiders sold a total of 16,150 shares of company stock worth $2,292,899 over the last 90 days. Corporate insiders own 17.00% of the company’s stock.

About Mesa Laboratories

Mesa Laboratories, Inc is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products.